The agencies said private equity firms are rolling up healthcare sectors through serialized purchases that fly under the radar of regulators, creating an unsustainable level of consolidation. 

Concerns stem from manufacturing and distribution of the BioZorb marker, with possible ramifications including "seizure, injunction and civil money penalties." 

Those proposing breast imaging-related measures so far in 2025 have included Connecticut, Florida, Hawaii, Indiana, Missouri, New York, South Carolina, Utah and Virginia, ACR reports. 

A new report from the Office of the Inspector General found the FDA failed to properly record meetings with drug manufacturers, ultimately approving drugs later shown to have safety and efficacy issues. 

Maquet Cardiovascular, a subsidiary of Getinge, is recalling two of its endoscopic vessel harvesting devices due to issues with different pieces bending, peeling or detaching during use. Some of the company's other EVH devices were recently involved in a separate recall for similar reasons. 

Some CPT billing code descriptions leave ambiguity as to the number of image views involved in an exam, resulting in variability in interpretation times.  

Tracy Young, CRNA, vice president at the American Association of Nurse Anesthesiology, details the ongoing fight between providers and insurers over how anesthesiologists get paid. 

CMS is accepting public comments on the topic for a period of 30 days. Recor Medical and Medtronic have both shared statements in support of the potential policy shift.